23
DEVICES
&
IMPLANTS
REQUEST A REVENUE CYCLE ASSESSMENT
REVENUE CYCLE
REDEFINING THE
2019
2019
866-948-7673 • nationalASCbilling.com
REVENUE CYCLE MANAGEMENT | MANAGED CARE CONTRACTING | CODING | BUSINESS ANALYTICS | CONSULTING | TRANSCRIPTION
THE ASC REVENUE CYCLE.
It's all we do.
It's all we think about.
And it shows.
10 numbers that show how big Johnson & Johnson is
in spine, orthopedics
By Laura Dyrda
J
ohnson & Johnson Medical Device Companies is a significant
player in the orthopedic and spine marketplace, holding the
No. 1 spot in orthopedics and No. 2 spot in spine.
DePuy Synthes drives Johnson & Johnson's orthopedics and spine
lines. Here are 10 numbers that illustrate how big the company is.
1. DePuy Synthes Companies generate around $10 billion in annual
sales.
2. DePuy Synthes Companies has around 18,000 employees in 60
countries.
3. Worldwide, the DePuy Synthes' products support around 1 million
orthopedic procedures per year.
4. In a survey of 107 patients who underwent outpatient total joint
replacement at four ASCs with DePuy Synthes products, 96.3 percent
said they would choose outpatient joint replacement again.
5. Johnson & Johnson has 16 percent of the spine market, according to
a report from e Spine Market Group.
6. Johnson & Johnson had around 21.8 percent of the orthopedics
market share in 2017 and is expected to have 24.2 percent in 2024,
according to Statista rankings.
7. In 2019, Johnson & Johnson reported worldwide orthopedic sales
of $8.8 billion.
8. Spine and other sales hit $3.2 billion last year.
9. Johnson & Johnson reported both hip and knee sales hit $1.4 billion
in 2019.
10. Last year, DePuy Synthes and Johnson & Johnson Medical Device
Companies launched, released or received FDA clearance for at least
seven products. n
